-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FRh1B3pLqGA4UE5pTRp9LBSCArVh6RIOaVd3h4CB9AykUUWzKYXDsnH4OIh8S2JJ Rg+a2Tr2GLgiH2be8xngVA== 0000893750-02-000136.txt : 20020414 0000893750-02-000136.hdr.sgml : 20020414 ACCESSION NUMBER: 0000893750-02-000136 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020219 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KKR 1996 FUND L P CENTRAL INDEX KEY: 0001031665 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: KOHLBERG KRAVIS ROBERTS & CO STREET 2: 9 WEST 57TH STREET SUITE 4200 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127508300 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDCATH CORP CENTRAL INDEX KEY: 0001139463 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 562248952 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-62451 FILM NUMBER: 02553396 BUSINESS ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 7047086600 MAIL ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 SC 13G 1 sc13g.txt MEDCATH CORP. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) MEDCATH CORPORATION - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par vaue $.01 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 58404W 10 9 - -------------------------------------------------------------------------------- (CUSIP Number) July 23, 2001 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. 58404W 10 9 Page 2 of 13 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MedCath 1998 LLC ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 5,568,522 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 0 _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 5,568,522 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH 0 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,568,522 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 30.9% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON 00 ________________________________________________________________________________ SCHEDULE 13G CUSIP No. 58404W 10 9 Page 3 of 13 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON KKR 1996 Fund L.P. ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 5,568,522 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 0 _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 5,568,522 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH 0 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,568,522 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 30.9% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON PN ________________________________________________________________________________ SCHEDULE 13G CUSIP No. 58404W 10 9 Page 4 of 13 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON KKR Associates 1996, L.P. ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 5,568,522 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 0 _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 5,568,522 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH 0 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,568,522 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 30.9% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON PN ________________________________________________________________________________ SCHEDULE 13G CUSIP No. 58404W 10 9 Page 5 of 13 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON KKR 1996 G.P. L.L.C. ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 5,568,522 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 0 _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 5,568,522 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH 0 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,568,522 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 30.9% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON 00 ________________________________________________________________________________ SCHEDULE 13G Item 1(a). Name of Issuer: MedCath Corporation Item 1(b). Address of Issuer's Principal Executive Offices: 10720 Sikes Place, Suite 300 Charlotte, North Carolina 28277 Item 2(a). Name of Persons Filing: Medcath 1998 LLC KKR 1996 Fund L.P. KKR Associates 1996, L.P. KKR 1996 G.P. L.L.C. Item 2(b). Address of Principal Business Office or, if None, Residence: c/o Kohlberg Kravis Roberts & Co. 9 West 57th Street New York, NY 10019 Item 2(c). Citizenship: Delaware Item 2(d). Title of Class of Securities: Common Stock, par value $0.01 per share Item 2(e). CUSIP Number: 58404W 10 9 Item 3. Not applicable. Item 4. Ownership. (a) Amount Beneficially Owned MedCath 1998 LLC holds directly, and has sole voting and dispositive power with respect to 5,568,522 shares of common stock of MedCath Corporation (the "Common Stock"). As the managing member of MedCath 1998 LLC, KKR 1996 Fund L.P. may be deemed to be the beneficial owner of the shares of Common Stock held by MedCath 1998 LLC. As the sole general partner of KKR 1996 Fund L.P., KKR Associates 1996, L.P. may also be deemed to be 6 the beneficial owner of the shares of Common Stock held by MedCath 1998 LLC. As the sole general partner of KKR Associates 1996, L.P., KKR 1996 G.P. L.L.C. may also be deemed to be the beneficial owner of the shares of Common Stock held by MedCath 1998 LLC. KKR 1996 G.P. L.L.C. is a Delaware limited liability company, the managing members of which are Messrs. Henry R. Kravis and George R. Roberts and the other members of which are Messrs. Robert I. MacDonnell, Paul E. Raether, Michael W. Michelson, James H. Greene, Jr., Michael T. Tokarz, Perry Golkin, Scott M. Stuart, Edward A. Gilhuly, Johannes Huth, Todd A. Fisher, Alexander Navab and Neil A. Richardson. Each of these individuals may be deemed to share beneficial ownership of any shares of Common Stock beneficially owned by KKR 1996 G.P. L.L.C., but each of such individuals disclaims any such beneficial ownership of such shares of Common Stock. (b) Percent of Class See Item 11 of each cover page, which is based upon Item 5 of each cover page. See Item 4(a). (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote See Item 5 of each cover page. (ii) shared power to vote or to direct the vote See Item 6 of each cover page. (iii) sole power to dispose or to direct the disposition of See Item 7 of each cover page. (iv) shared power to dispose or to direct the disposition of See Item 8 of each cover page. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. 7 Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. Not applicable. 8 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. MEDCATH 1998 LLC By: KKR 1996 Fund L.P., managing member By: KKR Associates 1996, L.P., general partner By: KKR 1996 G.P. L.L.C., general partner By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis KKR 1996 FUND L.P. By: KKR Associates 1996, L.P., general partner By: KKR 1996 G.P. L.L.C., general partner By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis KKR ASSOCIATES 1996, L.P. By: KKR 1996 G.P. L.L.C., general partner By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis 9 KKR 1996 G.P. L.L.C. By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis February 14, 2002 10 EXHIBITS Exhibit 1 - Joint Filing Agreement Exhibit 24 - Power of Attorney (already on file) 11 EXHIBIT 1 JOINT FILING AGREEMENT We, the signatories of the statement on Schedule 13G to which this Agreement is attached, hereby agree that such statement is, and any amendments thereto filed by any of us will be, filed on behalf of each of us. MEDCATH 1998 LLC By: KKR 1996 Fund L.P., managing member By: KKR Associates 1996, L.P., general partner By: KKR 1996 G.P. L.L.C., general partner By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis KKR 1996 FUND L.P. By: KKR Associates 1996, L.P., general partner By: KKR 1996 G.P. L.L.C., general partner By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis KKR ASSOCIATES 1996, L.P. By: KKR 1996 G.P. L.L.C., general partner By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis 12 KKR 1996 G.P. L.L.C. By: /s/ William J. Janetschek ------------------------- Name: William J. Janetschek Title: Attorney-in-fact for Henry R. Kravis 13 -----END PRIVACY-ENHANCED MESSAGE-----